DA-3031

pegylated granulocyte colony-stimulating factor (PEG-G-CSF) · Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DA-3031, covering 2014-10-01 to 2014-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia [Phase 3]